287 related articles for article (PubMed ID: 21447053)
1. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
Knobloch J; Hag H; Jungck D; Urban K; Koch A
Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.
Knobloch J; Wahl C; Feldmann M; Jungck D; Strauch J; Stoelben E; Koch A
Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):202-9. PubMed ID: 23981542
[TBL] [Abstract][Full Text] [Related]
4. Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects.
Gerlach K; Köhler-Bachmann S; Jungck D; Körber S; Yanik S; Knoop H; Wehde D; Rheinländer S; Walther JW; Kronsbein J; Knobloch J; Koch A
Eur J Pharmacol; 2015 Dec; 768():123-30. PubMed ID: 26526351
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD.
Culpitt SV; Rogers DF; Fenwick PS; Shah P; De Matos C; Russell RE; Barnes PJ; Donnelly LE
Thorax; 2003 Nov; 58(11):942-6. PubMed ID: 14586044
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages.
Armstrong J; Sargent C; Singh D
Clin Exp Immunol; 2009 Oct; 158(1):74-83. PubMed ID: 19737233
[TBL] [Abstract][Full Text] [Related]
7. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
Russell RE; Culpitt SV; DeMatos C; Donnelly L; Smith M; Wiggins J; Barnes PJ
Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
[TBL] [Abstract][Full Text] [Related]
8. Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.
Chana KK; Fenwick PS; Nicholson AG; Barnes PJ; Donnelly LE
J Allergy Clin Immunol; 2014 Jan; 133(1):207-16.e1-11. PubMed ID: 24176116
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease.
Armstrong J; Harbron C; Lea S; Booth G; Cadden P; Wreggett KA; Singh D
J Pharmacol Exp Ther; 2011 Sep; 338(3):732-40. PubMed ID: 21610141
[TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma.
John M; Lim S; Seybold J; Jose P; Robichaud A; O'Connor B; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 1998 Jan; 157(1):256-62. PubMed ID: 9445307
[TBL] [Abstract][Full Text] [Related]
11. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
Lea S; Plumb J; Metcalfe H; Spicer D; Woodman P; Fox JC; Singh D
Eur Respir J; 2014 Feb; 43(2):409-20. PubMed ID: 23794466
[TBL] [Abstract][Full Text] [Related]
12. [Effect of invigorating lung and kidney prescription and its components on secretion of cytokines induced by CSE and LPS].
Wu YS; Chen YL; Li JS; Liu XF; Hao LL; Tian YG; Li Y
Zhong Yao Cai; 2013 Jun; 36(6):961-6. PubMed ID: 24380286
[TBL] [Abstract][Full Text] [Related]
13. [Activation of transcription factors and induction of cytokines from macrophages in chronic obstructive pulmonary disease].
He B; Zhao M; Qi G
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1360-4. PubMed ID: 11930628
[TBL] [Abstract][Full Text] [Related]
14. [The study of inflammatory mediators and pulmonary ventilatory capacity in patients with chronic obstructive pulmonary disease].
He B; Zhao MW; Wang YZ; Liu XF; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):22-5. PubMed ID: 12775264
[TBL] [Abstract][Full Text] [Related]
15. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.
Culpitt SV; Rogers DF; Shah P; De Matos C; Russell RE; Donnelly LE; Barnes PJ
Am J Respir Crit Care Med; 2003 Jan; 167(1):24-31. PubMed ID: 12406856
[TBL] [Abstract][Full Text] [Related]
16. IL-5 release of CD4+ non-effector lymphocytes is increased in COPD--modulating effects of moxifloxacin and dexamethasone.
Schild K; Knobloch J; Yakin Y; Jungck D; Urban K; Müller K; Koch A
Int Immunopharmacol; 2011 Apr; 11(4):444-8. PubMed ID: 21215348
[TBL] [Abstract][Full Text] [Related]
17. The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages.
Lea SR; Reynolds SL; Kaur M; Simpson KD; Hall SR; Hessel EM; Singh D
Int J Chron Obstruct Pulmon Dis; 2018; 13():771-780. PubMed ID: 29535517
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by triptolide of chemokine, proinflammatory cytokine, and adhesion molecule expression induced by lipopolysaccharide in corneal fibroblasts.
Lu Y; Liu Y; Fukuda K; Nakamura Y; Kumagai N; Nishida T
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3796-800. PubMed ID: 16936090
[TBL] [Abstract][Full Text] [Related]
19. Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease.
Milara J; Lluch J; Almudever P; Freire J; Xiaozhong Q; Cortijo J
J Allergy Clin Immunol; 2014 Aug; 134(2):314-22. PubMed ID: 24636089
[TBL] [Abstract][Full Text] [Related]
20. Effect of lipoteichoic acid on IL-2 and IL-5 release from T lymphocytes in asthma and COPD.
Mat Z; Grensemann B; Yakin Y; Knobloch J; Koch A
Int Immunopharmacol; 2012 Jul; 13(3):284-91. PubMed ID: 22542695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
